Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer put under the microscope. Cramer discussed it while highlighting the performance of healthcare stocks. He said: “Some of these healthcare stocks seem played out already to you, perhaps. I mean, Merck was up 7% just today. Charitable holding Danaher also leaped more than 7%. But these stocks have been down so long, they look up to me. I believe they’ve got a lot more upside before they run out of steam. My Charitable Trust owns Danaher, and it ...

Danaher Corporation (NYSE:DHR) is one of the best medical stocks to buy now. On September 22, BofA lowered the firm’s price target on Danaher Corporation (NYSE:DHR) to $220 from $230 while keeping a Buy rating on the shares. Danaher Corporation (DHR) Is "Fool's Gold," Bemoans Jim Cramer The firm told investors that although some trends are showing stabilization and/or improvement in certain areas of Life Sciences and Diagnostic Tools, there exist several pockets of uncertainty and softness over the past ...